High-density lipoprotein function in rheumatoid arthritis

Current Opinion in Lipidology

Volumn 27, Issue 1, 2016, Pages 67-75

  Ormseth, Michelle J ^a   Stein, C Michael ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

atherosclerosis; cholesterol efflux; HDL; rheumatoid arthritis

Indexed keywords

HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ANTIOXIDANT;

ANTIOXIDANT ACTIVITY; CONTROLLED CLINICAL TRIAL (TOPIC); DISEASE ACTIVITY; HUMAN; INFLAMMATION; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; ANIMAL; METABOLISM;

ANIMALS; ANTIOXIDANTS; ARTHRITIS, RHEUMATOID; CHOLESTEROL, HDL; HUMANS; LIPOPROTEINS, HDL;

EID: 84954372855     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0000000000000256     Document Type: Review

References (16)

1. Chung CP, Oeser A, Raggi P, et al. Increased coronary-Artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum. 2005; 52: 3045-3053.
2. Liao KP, Cai T, Gainer VS, et al. Lipid and lipoprotein levels and trends in rheumatoid arthritis compared to the general population. Arthritis Care Res (Hoboken) 2013; 65: 2046-2050.
3. Rho YH, Chung CP, Oeser A, et al. Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2010; 62: 1473-1480.
4. Myasoedova E, Crowson CS, Kremers HM, et al. Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease. Ann Rheum Dis. 2011; 70: 482-487.
5. McMahon M, Grossman J, FitzGerald J, et al. Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum. 2006; 54: 2541-2549.
6. Charles-Schoeman C, Watanabe J, Lee YY, et al. Abnormal function of highdensity lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis. Arthritis Rheum. 2009; 60: 2870-2879.
7. Gomez Rosso L, Lhomme M, Merono T, et al. Altered lipidome and antioxidative activity of small, dense HDL in normolipidemic rheumatoid arthritis: relevance of inflammation. Atherosclerosis. 2014; 237: 652-660.
8. Charles-Schoeman C, Lee YY, Grijalva V, et al. Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis. Ann Rheum Dis. 2012; 71: 1157-1162.
9. Vivekanandan-Giri A, Slocum JL, Byun J, et al. High density lipoprotein is targeted for oxidation by myeloperoxidase in rheumatoid arthritis. Ann Rheum Dis. 2013; 72: 1725-1731.
10. Liao KP, Playford MP, Frits M, et al. The association between reduction in inflammation and changes in lipoprotein levels and HDL cholesterol efflux capacity in rheumatoid arthritis. J Am Heart Assoc. 2015; 4: e001588.
11. Ronda N, Favari E, Borghi MO, et al. Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis. 2014; 73: 609-615.
12. Ronda N, Greco D, Adorni MP, et al. Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism. Arthritis Rheumatol. 2015; 67: 1155-1164.
13. Pozzi FS, Maranhao RC, Guedes LK, et al. Plasma kinetics of an LDL-like non-protein nanoemulsion and transfer of lipids to high-density lipoprotein (HDL) in patients with rheumatoid arthritis. J Clin Lipidol. 2015; 9: 72-80.
14. Charles-Schoeman C, Fleischmann R, Davignon J, et al. Potential mechanisms leading to the abnormal lipid profile in patients with rheumatoid arthritis versus healthy volunteers and reversal by tofacitinib. Arthritis Rheumatol. 2015; 67: 616-625.
15. Kelesidis T, Currier JS, Huynh D, et al A biochemical fluorometric method for assessing the oxidative properties of HDL. J Lipid Res. 2011; 52: 2341-2351.
16. Ormseth MJ, Yancey PG, Yamamoto S, Oeser AM, et al. Cholesterol efflux capacity of HDL and coronary atherosclerosis in rheumatoid arthritis [abstract]. Arthritis Rheumatol. 2014; 66: S634.